Konrad Zuzda: A Challenging Case of Heparin-Free VV-ECMO for High-Risk Airway Management
Konrad Zuzda, Trainees Committee Member of European Society of Anaesthesiology and Intensive Care, Researcher PhD Student at Medical University of Warsaw – MUW, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:
“We’ve described a challenging case of heparin-free VV-ECMO for high-risk airway management in advanced laryngeal tumour obstruction.
A 48-hour journey where pre-emptive cannulation under local anesthesia gave us the breathing room to perform a technically demanding tracheostomy safely.
Grateful to our multidisciplinary team for thinking creatively when conventional options simply weren’t viable.”
Title: Elective Heparin-Free Veno-Venous Extracorporeal Membrane Oxygenation for High-Risk Airway Management in Advanced Laryngeal Tumor Obstruction: A Case Report
Authors: Joanna Prokop, Konrad Zuzda, Wojciech Jan Górski, Miłosz Jankowski, Eliza Brożek-Mądry, Konstanty Szułdrzyński
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering